Company Filing History:
Years Active: 2011
Title: The Innovations of Darren Di Salvo
Introduction
Darren Di Salvo is an accomplished inventor based in New Milford, CT (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific receptors in the body. His work has the potential to impact the treatment of various autoimmune diseases.
Latest Patents
Darren holds a patent for Azaindazole compounds as CCR1 receptor antagonists. This patent discloses compounds of the formula (I), which are useful for treating a variety of diseases and disorders mediated or sustained through the activity of CCR1. These include autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The patent also outlines methods of making and using these compounds.
Career Highlights
Darren is currently employed at Boehringer Ingelheim International GmbH, where he continues to innovate and develop new therapeutic solutions. His expertise in medicinal chemistry has been instrumental in advancing the company's research initiatives.
Collaborations
Darren has collaborated with notable colleagues, including Brian Nicholas Cook and Christian Harcken. These partnerships have fostered a collaborative environment that enhances the research and development process.
Conclusion
Darren Di Salvo's contributions to the field of medicinal chemistry and his innovative patent work exemplify the impact of dedicated inventors in advancing healthcare solutions. His ongoing efforts at Boehringer Ingelheim International GmbH continue to pave the way for new treatments for autoimmune diseases.